|
[1]
|
Rodriguez-Paredes, M. and Esteller, M. (2011) Cancer Epigenetics Reaches Mainstream Oncology. Nature Medicine, 17, 330-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Fraga, M.F., et al. (2005) Loss of Acetylation at Lys16 and Trimethylation at Lys20 of Histone H4 Is a Common Hallmark of Human Cancer. Nature Genetics, 37, 391-400. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kelly, T.K., De Carvalho, D.D. and Jones, P.A. (2010) Epigenetic Modifications as Therapeutic Targets. Nature Biotechnology, 28, 1069-1078. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Suzuki, S., et al. (2004) Specific Differences in Gene Expression Profile Revealed by cDNA Microarray Analysis of Glutathione S-Transferase Placental form (GST-P) Immunohistochemically Positive Rat Liver Foci and Surrounding Tissue. Carcinogenesis, 25, 439-443. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Xu, W., et al. (2001) A Transcriptional Switch Mediated by Cofactor Methylation. Science, 294, 2507-2511.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Koh, S.S., et al. (2002) Synergistic Coactivator Function by Coactivator-Associated Arginine Methyltransferase (CARM) 1 and β-Catenin with Two Different Classes of DNA-Binding Transcriptional Activators. The Journal of Biological Chemistry, 277, 26031-26035. [Google Scholar] [CrossRef]
|
|
[7]
|
Covic, M., et al. (2005) Arginine Methyltransferase CARM1 Is a Promoter-Specific Regulator of NF-κB-Dependent Gene Expression. The EMBO Journal, 24, 85-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wang, Y.P., et al. (2016) Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer. Molecular Cell, 64, 673-687. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Frietze, S., et al. (2008) CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-Regulation of E2F1. Cancer Research, 68, 301-306. [Google Scholar] [CrossRef]
|
|
[10]
|
Wang, L., et al. (2016) CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis. Cancer Cell, 30, 179-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Li, S., et al. (2017) The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/CyclinD1 Signaling Pathway. International Journal of Biological Sciences, 13, 976-984.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Osada, S., et al. (2006) Altered Gene Expression of Transcriptional Regulatory Factors in Tumor Marker-Positive Cells during Chemically Induced Hepatocarcinogenesis. Toxicology Letters, 167, 106-113.
[Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wei, X., et al. (2018) SKP2 Promotes Hepatocellular Carcinoma Progression through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction. Cellular Physiology and Biochemistry, 47, 2484-2497. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Stockert, J.C., et al. (2012) MTT Assay for Cell Viability: Intracellular Localization of the Formazan Product Is in Lipid Droplets. Acta Histochemica, 114, 785-796. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jian, W., et al. (2019) A Novel Role of HuR in Epigallocatechin-3-Gallate (EGCG) Induces Tumour Cells Apoptosis. Journal of Cellular and Molecular Medicine, 23, 3767-3771. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. The Lancet, 362, 1907-1917.
[Google Scholar] [CrossRef]
|
|
[17]
|
Han, T.S., et al. (2018) The Epigenetic Regulation of HCC Metastasis. International Journal of Molecular Sciences, 19, 3978. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Khan, F.S., et al. (2017) Epigenetic Mechanisms Regulating the Development of Hepatocellular Carcinoma and Their Promise for Therapeutics. Hepatology International, 11, 45-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Bedford, M.T. and Clarke, S.G. (2009) Protein Arginine Methylation in Mammals: Who, What, and Why. Molecular Cell, 33, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Su, Z., et al. (2015) Apoptosis, Autophagy, Necroptosis, and Cancer Metastasis. Molecular Cancer, 14, 48.
[Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Adams, J.M. and Cory, S. (2007) The Bcl-2 Apoptotic Switch in Cancer Development and Therapy. Oncogene, 26, 1324-1337. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Shigematsu, S., et al. (2011) ZNF689 Suppresses Apoptosis of Hepatocellular Carcinoma Cells through the Down-Regulation of Bcl-2 Family Members. Experimental Cell Research, 317, 1851-1859.
[Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Brito, A.F., et al. (2016) Targeting Hepatocellular Carcinoma: What Did We Discover So Far? Oncology Reviews, 10, 302. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Khalilzadeh, B., et al. (2018) Advances in Nanomaterial Based Optical Biosensing and Bioimaging of Apoptosis via Caspase-3 Activity: A Review. Microchimica Acta, 185, 434. [Google Scholar] [CrossRef] [PubMed]
|